ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #10,986Hybrid

Biopharmaceutics & Drug Disposition

Abbreviation (ISO):BIOPHARM DRUG DISPOS
•
Identifier (ISSN):0142-2782(Print)/1099-081X(Online)
•
Publisher:John Wiley and Sons Ltd
Clarivate IF (2026)
2.2↑ +0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Biopharmaceutics & Drug Disposition

WoS Q3
12231.6820181.6120191.6620201.6320211.8320222.120231.72024220252.22026
Annual Impact Factor Metric
Current (2026):2.2
Scopus SJR & RankScopus Q2
0.54
#10,986

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
72

72 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
38articles/year
22.73% Gold OA•89.66% Original Research

Aims & Scope

Biopharmaceutics & Drug Dispositionpublishes original review articles, short communications, and reports in biopharmaceutics, drug disposition, pharmacokinetics and pharmacodynamics, especially those that have a direct relation to the drug discovery/development and the therapeutic use of drugs. These includes: - animal and human pharmacological studies that focus on therapeutic response. pharmacodynamics, and toxicity related to plasma and tissue concentrations of drugs and their metabolites, - in vitro and in vivo drug absorption, distribution, metabolism, transport, and excretion studies that facilitate investigations related to the use of drugs in man - studies on membrane transport and enzymes, including their regulation and the impact of pharmacogenomics on drug absorption and disposition, - simulation and modeling in drug discovery and development - theoretical treatises - includes themed issues and reviews and exclude manuscripts on - bioavailability studies reporting only on simple PK parameters such as Cmax, tmax and t1/2 without mechanistic interpretation - analytical methods

Topics Covered (Recognized by AI)
Medicine91.3%Biology82.1%Chemistry77.5%Pharmacology76.3%Internal medicine76.3%Bioinformatics61.7%Endocrinology60.3%Pharmacokinetics59.8%Biochemistry56.1%Genetics41.6%Organic chemistry40.3%Physics32.7%Psychology29.1%Bioavailability25.5%Psychiatry23.9%Chromatography20.5%Materials science20.4%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank231/356
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank218/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.2
Articles / Year19
Total Citations5
2025
IF2
Articles / Year31
Total Citations24
2024
IF1.7
Articles / Year24
Total Citations80
2023
IF2.1
Articles / Year43
Total Citations234
2022
IF1.831
Articles / Year41
Total Citations281

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,986Scopus Q2SCImago Profile
Scopus Coverage:1979-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.54

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.66

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,881 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations197
3-Year Documents79
Citable Documents77

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate36.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2
Pharmaceutical ScienceQ2
PharmacologyQ3
Pharmacology (medical)Q3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Biopharmaceutics & Drug Disposition (abbr: BIOPHARM DRUG DISPOS, ISSN: 0142-2782) is a peer-reviewed international scholarly journal in the field of Medicine, published by John Wiley and Sons Ltd in England since 1979. The periodical holds a Journal Impact Factor (JIF) of 2.20, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.540 (Q2), an H-index of 72.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 38 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,881 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
John Wiley and Sons Ltd
Publication Language
English
Frequency
Monthly
Founding Year
1979
Indexing & Databases
SCIEScopusPubMed
Editorial Address
JOHN WILEY & SONS LTD, THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: e9178a57-af73-470f-ad90-004b9405e668
Database Updated: 2026-10-01